• 1
    Mino J-C. Assessing the outcome of palliative care. Eur J Palliat Care. 1999; 6: 203205.
  • 2
    McWhinney IR, Bass MJ, Donner A. Evaluation of a palliative care service: problems and pitfalls. BMJ. 1994; 309: 13401342.
  • 3
    Rinck GC, van den Bos GA, Kleijnen J, de Haes HJ, Schade E, Veenhof CH. Methodologic issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol. 1997; 15: 16971707.
  • 4
    Rinck G, Kleijnen J, Van den Bos TG, de Haes HJ, Schade E, Veenhof CH. Trials in palliative care. BMJ. 1995; 310: 598599.
  • 5
    Cohen RS, Ferrer-Brechner T, Pavlov A, Reading AE. Prospective evaluation of treatment outcome in patients referred to a cancer pain center. Clin J Pain. 1985; 1: 105109.
  • 6
    Mystakidou K, Tsilika E, Parpa E, Kalaidopoulou O, Smyrniotis V, Vlahos L. The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample. Int J Cancer. 2001; 94: 135139.
  • 7
    Goodwin DM, Higginson IJ, Myers K, Douglas HR, Normand CE. Effectiveness of palliative day care in improving pain, symptom control, and quality of life. J Pain Symptom Manage. 2003; 25: 202212.
  • 8
    Stromgren AS, Goldschmidt D, Groenvold M, et al. Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer. 2002; 94: 512520.
  • 9
    Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Sjogren P. Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer. 2002; 38: 788794.
  • 10
    Stromgren AS, Groenvold M, Petersen MAa, et al. Pain characteristics and treatment outcome for advanced cancer patients during the first week of specialized palliative care. J Pain Symptom Manage. 2003; 27: 105114.
  • 11
    Hollen PJ, Gralla RJ, Cox C, Eberly SW, Kris MG. A dilemma in analysis: issues in the serial measurement of quality of life in patients with advanced lung cancer. Lung Cancer. 1997; 18: 119136.
  • 12
    Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980; 45: 22202224.
  • 13
    Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991; 7: 69.
  • 14
    Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365376.
  • 15
    Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361370.
  • 16
    Smets EM, Garssen B, Bonke B, de Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995; 39: 315325.
  • 17
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189198.
  • 18
    Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000; 88: 21642171.
  • 19
    Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 scoring manual. 3rd edition. Brussels: EORTC Quality of Life Study Group, 2001.
  • 20
    George LK, Landerman R, Blazer DG, Anthony JC. Cognitive impairment. In: RobinsLN, RegierDA, editors. Psychiatric disorders in America, the epidemiologic catchment area study. New York: Macmillan, The Free Press, 1991: 291327.
  • 21
    Watt T, Groenvold M, Bjorner JB, Noerholm V, Rasmussen NA, Bech P. Fatigue in the Danish general population. Influence of sociodemographic factors and disease. J Epidemiol Community Health. 2000; 54: 827833.
  • 22
    Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951; 16: 297334.
  • 23
    Nunnally JC. Psychometric theory. 2nd edition. New York: McGraw-Hill, 1978.
  • 24
    Hopwood P, Stephens RJ, Machin D. Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Qual Life Res. 1994; 3: 339352.
  • 25
    Simon R, Wittes RE. Methodologic guidelines for reports of clinical trials. Cancer Treat Rep. 1985; 69: 13.
  • 26
    Chiu TY, Hu WY, Chen CY. Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan. Support Care Cancer. 2000; 8: 311313.
  • 27
    Cohen SR, Boston P, Mount BM, Porterfield P. Changes in quality of life following admission to palliative care units. Palliat Med. 2001; 15: 363371.
  • 28
    Jordhoy MS, Fayers P, Loge JH, Ahlner-Elmqvist M, Kaasa S. Quality of life in palliative cancer care: results from a cluster randomized trial. J Clin Oncol. 2001; 19: 38843894.
  • 29
    Radbruch L, Nauck F, Ostgathe C, et al. What are the problems in palliative care? Results from a representative survey. Support Care Cancer. 2003; 11: 442451.
  • 30
    Aaronson NK, Cull AM, Kaasa S, Sprangers MAG. The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update. In: SpilkerB, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd edition. Philadelphia: Lippincott-Raven, 1996: 179189.
  • 31
    Kopp I, Lorenz W, Rothmund M, Koller M. Relation between severe illness and non-completion of quality-of-life questionnaires by patients with rectal cancer. J R Soc Med. 2003; 96: 442448.